Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 32051-32100 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06105931
Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes
PHASE1Recruiting
15 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2028
2 conditions2 sponsors1 location
NCT06141473
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
PHASE3Recruiting
1,600 participants
Started: Dec 13, 2023 · Completed: May 6, 2027
1 condition1 sponsor358 locations
NCT06184100
Virtual Self-Management Program for JIA
NARecruiting
100 participants
Started: Dec 13, 2023 · Completed: Mar 31, 2026
1 condition6 sponsors1 location
NCT05894122
Evaluation of Capillary Blood Collection Devices (Mitra® and HemaPEN®)
N/ARecruiting
40 participants
Started: Dec 13, 2023 · Completed: Dec 12, 2025
2 conditions1 sponsor1 location
NCT06219941
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
PHASE2Recruiting
190 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
4 conditions1 sponsor51 locations
NCT05839392
Novel Approaches to Target MECOM/EVI1 in AML
NARecruiting
24 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05761223
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
PHASE1/PHASE2Recruiting
151 participants
Started: Dec 13, 2023 · Completed: Oct 31, 2026
1 condition2 sponsors5 locations
NCT06083870
An Early Stage Study to Evaluate Oba01 for Injection in Patients With DR5 Positive LA/mNSCLC
PHASE1Recruiting
35 participants
Started: Dec 13, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06164925
Standardising and Simplifying the Global Leadership Initiative on Malnutrition (GLIM) for Its More General Application
N/ARecruiting
300 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT06203899
Depression and Suicide Prevention in Adolescents Attending Special Schools
NARecruiting
236 participants
Started: Dec 13, 2023 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT06282588
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
PHASE2/PHASE3Recruiting
493 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2030
1 condition3 sponsors11 locations
NCT04997993
Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer
PHASE1Recruiting
24 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06092554
Probiotics to Actively Counter Ventilator Associated Pneumonia (PROACT)
NARecruiting
186 participants
Started: Dec 13, 2023 · Completed: Jul 15, 2026
1 condition2 sponsors9 locations
NCT06367894
Treatment Optimization and Nephrolithiasis Recurrence Prevention With Interdisciplinary Care
N/ARecruiting
164 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05714930
LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus
NARecruiting
606 participants
Started: Dec 12, 2023 · Completed: Sep 30, 2026
1 condition4 sponsors14 locations
NCT06221020
To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery
N/ARecruiting
70 participants
Started: Dec 12, 2023 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT06026371
Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation
PHASE2Recruiting
138 participants
Started: Dec 12, 2023 · Completed: Mar 31, 2027
2 conditions1 sponsor1 location
NCT06166862
Action Observation and Motor Imagery Therapy in Stroke
NARecruiting
56 participants
Started: Dec 12, 2023 · Completed: Dec 30, 2024
1 condition2 sponsors1 location
NCT06083220
School Readiness in Preschool-Aged Children With Cerebral Palsy
NARecruiting
20 participants
Started: Dec 12, 2023 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT06141460
Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
PHASE1/PHASE2Recruiting
48 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06134479
Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.
PHASE3Recruiting
194 participants
Started: Dec 12, 2023 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT06316115
Effect On Paın And Anxıety Of Stress Ball Use Durıng Sharp Debrıdement
NARecruiting
76 participants
Started: Dec 12, 2023 · Completed: Apr 10, 2024
1 condition1 sponsor1 location
NCT06681844
Predict Tooth Wear
N/ARecruiting
1,000 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor5 locations
NCT06145230
A Cross-sectional Survey of Colorectal Cancer Patients in Different Age Groups
N/ARecruiting
430 participants
Started: Dec 12, 2023 · Completed: Dec 1, 2024
2 conditions1 sponsor1 location
NCT06172764
A Randomized Controlled Trial of Vitamin D Supplementation on Salivary Biomarkers and Cariogenic Oral Microbiome
PHASE4Recruiting
90 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT06040268
Advair HFA in Healthy and HAPE Predisposed Subjects
PHASE1/PHASE2Recruiting
60 participants
Started: Dec 12, 2023 · Completed: Dec 15, 2026
1 condition2 sponsors1 location
NCT06176170
VividWhite Glaucoma Implant (VW-51) Pivotal Study
NARecruiting
65 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor6 locations
NCT06417827
Artificial Intelligence for Mental Health Diagnoses and Treatment Plans: A Protocol for Actors and Patients
NARecruiting
220 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06213077
The Effects of a Nitrate Supplementation on Erectile Function
NARecruiting
20 participants
Started: Dec 12, 2023 · Completed: May 30, 2024
1 condition1 sponsor1 location
NCT05835505
Detoxification of the Liver In PSC (Dolphin)
PHASE2Recruiting
28 participants
Started: Dec 12, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT06576986
Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy
NARecruiting
80 participants
Started: Dec 12, 2023 · Completed: Dec 12, 2026
1 condition1 sponsor1 location
NCT06154083
INtensity of OVarian Stimualtion and Euploid Embryos
PHASE4Recruiting
110 participants
Started: Dec 12, 2023 · Completed: May 15, 2026
1 condition1 sponsor1 location
NCT06064825
Long Term Follow-up of the TREOCAPA Study (TREOCAPA-LT)
N/ARecruiting
500 participants
Started: Dec 12, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor8 locations
NCT05995496
Changes in Inhibition and Valuation After Eating
NARecruiting
150 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05849155
Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition
N/ARecruiting
125 participants
Started: Dec 12, 2023 · Completed: Oct 31, 2028
1 condition1 sponsor1 location
NCT06344117
Assessment of Volatile Organic Compounds (VOC) for the Diagnosis of Invasive Aspergillosis (IA) in Lung Transplant Recipients
N/ARecruiting
45 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05861895
A Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HF158K1 in Participants With HER-2 Positive or HER-2 Low Expression Advanced Solid Tumors
PHASE1Recruiting
84 participants
Started: Dec 12, 2023 · Completed: Dec 22, 2025
1 condition1 sponsor1 location
NCT07057622
A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With NETs
PHASE3Recruiting
184 participants
Started: Dec 12, 2023 · Completed: Feb 24, 2027
1 condition1 sponsor1 location
NCT06146426
Effects of Early Oral Diet After Cardiac Surgery: an Open Label Randomized Controlled Trial
NARecruiting
196 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06205979
Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents
EARLY_PHASE1Recruiting
50 participants
Started: Dec 12, 2023 · Completed: Jun 14, 2024
1 condition1 sponsor1 location
NCT06154447
Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis
PHASE1Recruiting
255 participants
Started: Dec 12, 2023 · Completed: Apr 23, 2026
1 condition1 sponsor10 locations
NCT06185205
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
PHASE2Recruiting
170 participants
Started: Dec 12, 2023 · Completed: Jan 31, 2033
1 condition1 sponsor1 location
NCT06228638
CognivAiD Real-World Evidence Clinical Registry (CONNECT Registry)
N/ARecruiting
100 participants
Started: Dec 12, 2023 · Completed: Jan 31, 2025
2 conditions1 sponsor1 location
NCT06163118
Validation of a Screening Tool for Swallowing Disorders for the Elderly
NARecruiting
40 participants
Started: Dec 12, 2023 · Completed: Dec 20, 2024
2 conditions1 sponsor1 location
NCT06224842
Clinical Study of Mitoxantrone Liposome and Azacitidine in the Treatment of R/R AITL
PHASE1/PHASE2Recruiting
30 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT06795958
Non-invasive Detection of Acute Cell-mediated Graft Rejection in Pediatric Heart Transplant Recipients
N/ARecruiting
30 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06814483
Effects Multimodal Mind and Body Approach for MCI
NARecruiting
30 participants
Started: Dec 12, 2023 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT05349006
Azathioprine in MOGAD
PHASE3Recruiting
126 participants
Started: Dec 12, 2023 · Completed: Dec 12, 2029
2 conditions1 sponsor17 locations
NCT06035744
CLN-617 Alone and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
PHASE1Recruiting
86 participants
Started: Dec 12, 2023 · Completed: Jun 30, 2028
1 condition1 sponsor5 locations
NCT07116889
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD
PHASE1Recruiting
156 participants
Started: Dec 12, 2023 · Completed: May 31, 2027
2 conditions1 sponsor13 locations